ArticleACS omega2025
Bioengineered Injectable Hydrogel Based on the Dentin Extracellular Matrix and Chitosan.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A detoxified exosome-ECM hydrogel depot for localized and sustained chemotherapy in prostate cancer.Journal of biological engineering · 2026Article
- Functionalization of Photocrosslinkable GelMA Hydrogel With Metal Oxides for Direct Pulp Capping.BioMed research international · 2026Article
- Bioinspired smart dentin ECM-chitosan hydrogels for dentin-pulp complex regeneration.Journal of dentistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The extracellular matrix of dentin contains macromolecules of biological value that make it a natural source for the prospection of novel smart biomaterials. Here, we described the development of an injectable thermosensitive smart hydrogel resulting from the blending of insoluble macromolecules of the dentin matrix and chitosan. The extrudability and gelation parameters of the prehydrogel were optimized by varying the concentration of individual components. Three-dimensional constructs were fabricated upon injection of the prehydrogel into custom-made molds, followed by incubation at 37 °C. Specimens were characterized for spectral, physical, morphological, mechanical, and biocompatibility features. Fourier-transform infrared (FTIR) analyses confirmed the integration of the dentin organic matrix and chitosan. The degree of porosity of constructs was ∼51%. The water diffusion of constructs reached a plateau after 2 days. Their moduli of elasticity were at a low MPa order, decreasing after storage in simulated body fluid (SBF). The biodegradability of constructs rose following incubation in SBF containing lysozyme or zinc ions. Hydrogel bioactivity was confirmed by FTIR and ultramorphologically suggested by surface precipitates. Hydrogel constructs were shown to be biocompatible with undifferentiated pulp cells (OD-21). Overall, the novel engineered injectable hydrogel based on dentin extracellular macromolecules and chitosan holds promising features for use as a scaffold for the regeneration of damaged load-bearing tissues like dentin and bone.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.